Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

IMPAX LABORATORIES INC (IPXL) > Segments

Impax Generics > Oxymorphone HCI ER family

Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13Dec-31-12Dec-31-11Dec-31-10
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues  68.672.759.265.3    
            Revenue growth  -5.6%22.8%-9.4%     
   
Revenue Mix  8.8%8.8%6.9%11.0%    

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy